XML 15 R9.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating activities:        
Net income (loss) $ 434 $ (390) $ 937 $ (1,684)
Adjustments to reconcile net income (loss) to net cash provided by operations:        
Depreciation and amortization 249 259 742 790
Impairment of goodwill 0 600 0 1,000
Impairment of long-lived assets and assets held for sale 79 (51) 255 758
Net change in operating assets and liabilities (561) 317 (1,595) (190)
Deferred income taxes – net and uncertain tax positions 107 (53) (76) (666)
Stock-based compensation 34 29 106 89
Other items [1] 27 2 122 597
Net loss (gain) from sale of business and long-lived assets 0 (21) 0 (22)
Net cash provided by (used in) operating activities 369 693 491 672
Investing activities:        
Beneficial interest collected in exchange for securitized trade receivables 274 339 932 951
Purchases of property, plant and equipment and intangible assets (136) (148) (359) (369)
Proceeds from sale of business and long-lived assets, net 8 38 34 39
Acquisition of businesses, net of cash acquired 0 0 0 (15)
Purchases of investments and other assets (13) (1) (40) (56)
Proceeds from sale of investments 0 40 0 40
Other investing activities 2 0 5 0
Net cash provided by (used in) investing activities 135 268 572 590
Financing activities:        
Repayment of senior notes and loans and other long term liabilities (444) 0 (4,112) (956)
Proceeds from senior notes, net of issuance costs (7) 0 2,298 0
Purchase of shares from redeemable and non-redeemable non-controlling interests 0 0 (38) (64)
Dividends paid to redeemable and non-redeemable non-controlling interests 0 0 (340) (78)
Other financing activities (2) 0 1 (19)
Net cash provided by (used in) financing activities (453) 0 (2,191) (1,117)
Translation adjustment on cash and cash equivalents (9) 100 31 (53)
Net change in cash and cash equivalents 42 1,061 (1,097) 92
Balance of cash, cash equivalents at beginning of period 2,161 2,258 3,300 3,227
Balance of cash, cash equivalents at end of period 2,203 3,319 2,203 3,319
Non-cash financing and investing activities:        
Beneficial interest obtained in exchange for securitized accounts receivables $ 296 $ 332 $ 937 $ 964
[1] Adjustment in the nine-month period ended September 30, 2024 was mainly related to an agreement with the Israeli Tax Authorities. See note 11.